These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8277511

  • 1. Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.
    Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TJ, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW.
    J Med Chem; 1993 Dec 24; 36(26):4293-301. PubMed ID: 8277511
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
    Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK.
    J Med Chem; 1997 Mar 14; 40(6):1026-40. PubMed ID: 9083493
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G.
    Biochemistry; 1994 Mar 01; 33(8):2089-95. PubMed ID: 8117665
    [Abstract] [Full Text] [Related]

  • 6. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
    Welch AR, Holman CM, Huber M, Brenner MC, Browner MF, Van Wart HE.
    Biochemistry; 1996 Aug 06; 35(31):10103-9. PubMed ID: 8756473
    [Abstract] [Full Text] [Related]

  • 7. Substance P induces the secretion of gelatinase A from human synovial fibroblasts.
    Hecker-Kia A, Kolkenbrock H, Orgel D, Zimmermann B, Sparmann M, Ulbrich N.
    Eur J Clin Chem Clin Biochem; 1997 Sep 06; 35(9):655-60. PubMed ID: 9352227
    [Abstract] [Full Text] [Related]

  • 8. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions.
    Butler GS, Apte SS, Willenbrock F, Murphy G.
    J Biol Chem; 1999 Apr 16; 274(16):10846-51. PubMed ID: 10196161
    [Abstract] [Full Text] [Related]

  • 9. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP, Dean DD, Schwartz Z, Cochran DL, Grant GM, Klebe RJ, Nakaya H, Boyan BD.
    J Cell Biochem; 1996 Jun 01; 61(3):375-91. PubMed ID: 8761942
    [Abstract] [Full Text] [Related]

  • 10. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
    Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA.
    J Clin Pathol; 1994 Feb 01; 47(2):113-6. PubMed ID: 8132824
    [Abstract] [Full Text] [Related]

  • 11. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
    Stack MS, Emberts CG, Gray RD.
    Arch Biochem Biophys; 1991 Jun 01; 287(2):240-9. PubMed ID: 1654808
    [Abstract] [Full Text] [Related]

  • 12. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW, Williams H, Hoernner LA, Weidner J, Ayala JM, Harper CF, Christen A, Olszewski J, Konteatis Z, Webber R.
    Biochem J; 1995 Apr 01; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases.
    Johnson LL, Dyer R, Hupe DJ.
    Curr Opin Chem Biol; 1998 Aug 01; 2(4):466-71. PubMed ID: 9736919
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 15. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
    Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A.
    Biochemistry; 1994 Nov 29; 33(47):14109-14. PubMed ID: 7947821
    [Abstract] [Full Text] [Related]

  • 16. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts.
    Svendsrud DH, Loennechen T, Winberg JO.
    Biochem Pharmacol; 1997 May 15; 53(10):1511-20. PubMed ID: 9260879
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
    Odake S, Morita Y, Morikawa T, Yoshida N, Hori H, Nagai Y.
    Biochem Biophys Res Commun; 1994 Mar 30; 199(3):1442-6. PubMed ID: 8147888
    [Abstract] [Full Text] [Related]

  • 18. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y.
    Eur J Biochem; 1998 Apr 01; 253(1):67-75. PubMed ID: 9578462
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
    Samples JR, Alexander JP, Acott TS.
    Invest Ophthalmol Vis Sci; 1993 Nov 01; 34(12):3386-95. PubMed ID: 8225873
    [Abstract] [Full Text] [Related]

  • 20. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL, Harber GJ, DeCarlo AA, Louis P, Shaneyfelt S, Windsor LJ, Bodden MK.
    J Dent Res; 1999 Jul 01; 78(7):1354-61. PubMed ID: 10403463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.